Post-Oncology Discharge Guidance

1. Radiation therapy: After short-term recovery after discharge, radiation therapy must be performed at the oncology hospital to consolidate the efficacy and reduce the chance of recurrence. 2. Periodic review: Before discharge from hospital, review once the visual acuity, visual field, fundus, blood electrolytes and MRI (or CT, including coronal scan and enhancement). The film of this imaging examination is for later review and comparison. After discharge, the review will be done every 3 months, half yearly after 2 years, and once a year after 5 years, which needs to be insisted for 10-20 years in order to know whether there is any recurrence of tumor. 3. Treatment of urinary collapse: If the hourly urine volume is more than 150ml (more than 3600ml per 24 hours) at the time of discharge, it is still necessary to continue to apply anti-diuretics and potassium chloride, and monitor the electrolyte changes. Oral mydriatics (0.1 mg/tablet) are recommended, one tablet in the morning and one tablet in the evening or one tablet daily, depending on the urine output. The dose of potassium chloride can be supplemented with 1 g according to the urine volume of 1000 ml and adjusted according to blood potassium monitoring. 4. Hormone replacement therapy: Dexamethasone must be continued for 1-2 months after discharge from the hospital, during which the dosage is gradually reduced before it can be stopped. Specific usage such as 0.75mg/tablet twice a day at discharge, change to 0.75mg/tablet once a day for about a week, change to 0.75mg/tablet once a day after 1-2 weeks, stop after 1-2 weeks. If mental atrophy and loss of appetite occur after drug reduction or discontinuation, it may be due to insufficient amount of hormone; dexamethasone 10mg can be used as an IV or intramuscular injection, and the earlier oral dose can be resumed after improvement. Other hormones, such as thyroxine or sex hormones, must be decided by the relevant specialist. 5. Application of antiepileptic drugs: For those who have never had convulsions, continue to take oral phenytoin sodium or sodium valproate drugs for 1 month after discharge. For those who have had convulsions but not diagnosed, continue to take phenytoin sodium or sodium valproate orally for 6 months to 1 year after discharge. For those with diagnosed epilepsy, continue to take phenytoin sodium or sodium valproate orally for 1 year to 3 years after discharge. The specific dose of phenytoin sodium 0.1/tablet three times a day or sodium valproate 0.2/tablet three times a day. If there is no convulsive seizure after 6 months, the dose can be changed to 1 tablet twice a day; after another 6 months without seizure, the dose can be changed to 1 tablet daily until 3 years of discontinuation. The medication should not be missed or stopped suddenly to induce seizures. Other treatment: Female patients with lactation, amenorrhea, irregular menstruation or infertility can see a gynecologist or endocrinologist. Male patients with impotence, infertility, etc. may see a urologist or endocrinologist.